Daily Archive: November 10, 2011

Nov 10

What to do in post PCI patient with hypotension?

Hypotension following PCI is not uncommon and should be vigorously investigated and treated writes Dr. Lekha Adik Pathak and Dr. Salil P. Shirodkar from Mumbai in the Cardiology update book being released in 63rd CSI meet being held early next month.  It is important as hypotension from any cause may decrease coronary blood flow and …

Continue reading »

Nov 10

After how long should one do a stress test after PCI or CABG

American College of Cardiology and American Heart Association does not recommend routine stress testing within two years of a per-cutaneous coronary intervention (PCI) or five years of coronary artery bypass grafting (CABG), unless symptoms or events provide a reason. 

Nov 10

Transcatheter Valves

Renu Virmani on Transcatheter Valves When Dr Renu Virmani (CVPath Institute, Gaithersburg, MD) looks to the past to make predictions about the future, people sit up and listen. Training her binoculars on the durability of transcatheter valves, Virmani made a prediction that was music to most of the ears in her audience here at TCT 2011. “I think …

Continue reading »

Nov 10

Hype or Hazard? Longitudinal Stent Compression Hashed Out

Interventional cardiologists here at TCT 2011 are hashing over the emerging issue of longitudinal stent compression, with the bulk of experts concluding that this phenomenon is rare, grabbing undue attention, and in many cases avoidable with meticulous technique. Most agreed, however, that stent design may play a factor in making some stents more vulnerable than others. Two …

Continue reading »

Nov 10

Steeper Learning with Transradial Interventions

A couple of new studies suggest that the learning curve for transradial-access PCI is steeper than first thought but that if the approach is taught early in training, interventionalists can become proficient accessing the heart via the radial artery. Presenting data this week at TCT 2011, lead investigator Dr Usman Javed (University of California, Davis) reported that transradial …

Continue reading »

Nov 10

Target Dose of Angiotensin II Receptor Antagonists in Patients with Heart Failure

1.  When using losartan or valsartan for the treatment of heart failure (HF), it is recommended that patients be titrated to target doses (i.e., losartan 150 mg daily; valsartan 160 mg twice daily), whenever possible. 2.  In an analysis of HF registry data of 5139 patients in Sweden, those treated with candesartan, had improved survival …

Continue reading »